| Biomarker ID | 645 |
| PMID | 21520154 |
| Year | 2011 |
| Biomarker | PSGR |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulted in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- Olfactory transduction,Signaling by GPCR |
| Experiment | Prostate Cancer Vs Benign |
| Type of Biomarker | Diagnostic |
| Cohort | Samples for Benign (n=97) and PCA (n=57) were taken into account for this study. |
| Senstivity | 63% |
| Specificity | 64% |
| AUC | 0.65 |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | qPCR |
| Clinical | No |
| Remarks | Briefly, 50% of the sample was used as a training set to compute a ROC curve. |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | OR51E2 |